Clinical study to examine the effectiveness of Juzentaihoto in postoperative recovery for colorectal cancer patients - A research investigating the role of cell-mediated immunity in recovery - Clinical study to examine the effectiveness of Juzentaihoto in postoperative recovery for colorectal cancer patients - A research investigating the role of cell-mediated immunity in recovery

Sapporo Medical University School of Medicine First Department of Surgery0 个研究点目标入组 20 人开始时间: 2008年7月8日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•1.Patients who did not have complete resection of their bowels 2.Patients who took Traditional Japanese Medicine within four weeks of their surgery 3.Patients who are unable to take the test medication one week after the surgery 4.Patients with preoperative laboratory values falling within the ranges as described below, and their main organs (bone marrow, heart, lungs, kidneys and liver) show advanced, functional disorders: *WBC<or=4,000/mm3 or 12,000/mm3<or=WBC *Platelets<or=100,000/mm3 *Hemoglobin<or=10g/dl *AST (SGOT serum glutamic-oxaloacetic transaminase) > 2x above upper normal range *ALT (SGPT serum glutamic-pyruvic transaminase) > 2x above upper normal range *Serum total bilirubin>or=2.0mg/dl *BUN<or=25mg/dl *Serum creatinine >or=1.5mg/dl 5.Patients who have serious, postoperative complications including infection, diarrhea (watery stool), tube paralysis, bowel obstruction with pleural effusion, ascites or hydropericardium 6.Patients who have clinically active inflammation or complication 7.Patients who are pregnant or are possibly pregnant 8.Patients who fail to meet the eligibility criteria for the study 9.Patients who are unable to sign a written consent 10. Patients who are determined to be unfit for the study by the physician in charge of the research

发起方

Sapporo Medical University School of Medicine First Department of Surgery